Edition:
United Kingdom

Genocea Biosciences Inc (GNCA.OQ)

GNCA.OQ on NASDAQ Stock Exchange Global Market

1.02USD
23 Feb 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.02
Open
$1.03
Day's High
$1.04
Day's Low
$1.01
Volume
178,630
Avg. Vol
167,957
52-wk High
$7.28
52-wk Low
$0.79

Latest Key Developments (Source: Significant Developments)

New Enterprise Associates 16 Reports A 39.7 Pct Stake In Genocea Biosciences As Of Jan 17
Friday, 26 Jan 2018 

Jan 26 (Reuters) - Genocea Biosciences Inc ::NEW ENTERPRISE ASSOCIATES 16, L.P. REPORTS A 39.7 PERCENT STAKE IN GENOCEA BIOSCIENCES INC AS OF JAN 17 - SEC FILING.  Full Article

Genocea Biosciences Announces Proposed Concurrent Public Offerings Of Common Stock
Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - Genocea Biosciences Inc ::GENOCEA BIOSCIENCES, INC. ANNOUNCES PROPOSED CONCURRENT PUBLIC OFFERINGS OF COMMON STOCK AND CLASS A WARRANTS AND SERIES A CONVERTIBLE PREFERRED STOCK AND CLASS A WARRANTS.GENOCEA BIOSCIENCES INC - ‍GENOCEA INTENDS TO USE NET PROCEEDS FROM CONCURRENT OFFERINGS TO SUPPORT ONGOING DEVELOPMENT OF ITS GEN-009 PROGRAM​.  Full Article

Genocea Biosciences inc qtrly ‍loss per share $0.59​
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Genocea Biosciences Inc :Genocea reports third quarter 2017 financial results.Genocea biosciences - ‍expects existing cash and cash equivalents sufficient to support operating expenses and capital expenditure into middle of 2018​.Genocea biosciences inc - ‍cash and cash equivalents as of september 30, 2017 were $22.0 million compared to $35.2 million as of june 30, 2017​.Genocea biosciences inc qtrly ‍loss per share $0.59​.Q3 earnings per share view $-0.53 -- Thomson Reuters I/B/E/S.  Full Article

Genocea qtrly loss per share $0.39
Thursday, 4 Aug 2016 

Genocea Biosciences Inc : Genocea reports second quarter 2016 financial results . Qtrly loss per share $0.39 .Expects that cash, cash equivalents to be sufficient to fund operating expenses, capex requirements into second half of 2017.  Full Article

BRIEF-Genocea Qtrly Loss Per Share $0.37

* GENOCEA REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS